) today announced sales results for September. Monthly Sales For the four weeks ended Sept. 29, 2012, same store sales decreased 0.7 percent over the prior-year period. September front-end same store sales increased 2.8 percent. Pharmacy same store sales, which included an approximate 911 basis points negative impact from new generic introductions, decreased 2.3 percent. Prescription count at comparable stores increased 4.4 percent over the prior-year period. Total drugstore sales for the four-week period decreased 1.5 percent to $1.899 billion compared to $1.927 billion for the same period last year. Prescription sales accounted for 67.8 percent of drugstore sales, and third party prescription sales represented 96.5 percent of pharmacy sales. Year-to-Date Sales Same store sales for the 30-week period ended Sept. 29, 2012 increased 0.9 percent over the prior-year period. Front-end same store sales increased 2.1 percent while pharmacy same store sales increased 0.4 percent. Prescription count at comparable stores increased 3.6 percent over the prior-year period. Total drugstore sales for the 30 weeks ended Sept. 29, 2012 increased 0.2 percent with sales of $14.545 billion compared to $14.513 billion for the same period last year. Prescription sales represented 67.9 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.